These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 19527717

  • 1. A selective small-molecule inhibitor of c-Jun N-terminal kinase 1.
    Yao K, Cho YY, Bode AM, Vummenthala A, Park JG, Liu K, Pang YP, Dong Z.
    FEBS Lett; 2009 Jul 07; 583(13):2208-12. PubMed ID: 19527717
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y, Taura K, Miura K, Schnabl B, Osawa Y, Brenner DA.
    Gastroenterology; 2009 Apr 07; 136(4):1423-34. PubMed ID: 19249395
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
    Yeap YY, Ng IH, Badrian B, Nguyen TV, Yip YY, Dhillon AS, Mutsaers SE, Silke J, Bogoyevitch MA, Ng DC.
    Biochem J; 2010 Sep 01; 430(2):345-54. PubMed ID: 20594188
    [Abstract] [Full Text] [Related]

  • 6. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.
    Ma FY, Flanc RS, Tesch GH, Han Y, Atkins RC, Bennett BL, Friedman GC, Fan JH, Nikolic-Paterson DJ.
    J Am Soc Nephrol; 2007 Feb 01; 18(2):472-84. PubMed ID: 17202416
    [Abstract] [Full Text] [Related]

  • 7. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D, Donin N, Fishelson Z.
    Mol Immunol; 2009 Dec 01; 47(2-3):310-7. PubMed ID: 19864026
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3.
    Swahn BM, Huerta F, Kallin E, Malmström J, Weigelt T, Viklund J, Womack P, Xue Y, Ohberg L.
    Bioorg Med Chem Lett; 2005 Nov 15; 15(22):5095-9. PubMed ID: 16140012
    [Abstract] [Full Text] [Related]

  • 9. Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity.
    Szczepankiewicz BG, Kosogof C, Nelson LT, Liu G, Liu B, Zhao H, Serby MD, Xin Z, Liu M, Gum RJ, Haasch DL, Wang S, Clampit JE, Johnson EF, Lubben TH, Stashko MA, Olejniczak ET, Sun C, Dorwin SA, Haskins K, Abad-Zapatero C, Fry EH, Hutchins CW, Sham HL, Rondinone CM, Trevillyan JM.
    J Med Chem; 2006 Jun 15; 49(12):3563-80. PubMed ID: 16759099
    [Abstract] [Full Text] [Related]

  • 10. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
    Oleinik NV, Krupenko NI, Krupenko SA.
    Oncogene; 2007 Nov 08; 26(51):7222-30. PubMed ID: 17525747
    [Abstract] [Full Text] [Related]

  • 11. Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration.
    Probst GD, Bowers S, Sealy JM, Truong AP, Hom RK, Galemmo RA, Konradi AW, Sham HL, Quincy DA, Pan H, Yao N, Lin M, Tóth G, Artis DR, Zmolek W, Wong K, Qin A, Lorentzen C, Nakamura DF, Quinn KP, Sauer JM, Powell K, Ruslim L, Wright S, Chereau D, Ren Z, Anderson JP, Bard F, Yednock TA, Griswold-Prenner I.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):315-9. PubMed ID: 21112785
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury.
    Pirianov G, Brywe KG, Mallard C, Edwards AD, Flavell RA, Hagberg H, Mehmet H.
    J Cereb Blood Flow Metab; 2007 May 01; 27(5):1022-32. PubMed ID: 17063149
    [Abstract] [Full Text] [Related]

  • 19. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J, Minemoto Y, Lin A.
    Mol Cell Biol; 2004 Dec 01; 24(24):10844-56. PubMed ID: 15572687
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.